SCHEMBL8328740

SCHEMBL8328740

CSc1ccnc(C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 5/20 0.55
MAPT P10636 3/20 0.55
KDM5A P29375 2/20 0.55
KDM3A Q9Y4C1 2/20 0.55
KDM6B O15054 1/20 0.55
TET3 O43151 1/20 0.55
KDM4A O75164 1/20 0.55
BBOX1 O75936 1/20 0.55
KDM5C P41229 1/20 0.55
ASPH Q12797 1/20 0.55
KDM4D Q6B0I6 1/20 0.55
TET2 Q6N021 1/20 0.55
ALKBH5 Q6P6C2 1/20 0.55
KDM7A Q6ZMT4 1/20 0.55
KDM8 Q8N371 1/20 0.55
TET1 Q8NFU7 1/20 0.55
EGLN2 Q96KS0 1/20 0.55
FTO Q9C0B1 1/20 0.55
EGLN1 Q9GZT9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2918024 0.85 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTKDM5AKDM3A
SCHEMBL2097713 0.84 KDM4E (0.59) ALDH1A1KDM4EMAPTKDM5AKDM3A
SCHEMBL9331740 0.83 NPC1 (0.44) ALDH1A1KDM4EMAPTKDM5AKDM3A
SCHEMBL11504946 0.82 KDM4E (0.57) ALDH1A1KDM4EMAPTKDM5AKDM3A
SCHEMBL9332309 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPTKDM5AKDM3A
SCHEMBL13232701 0.80 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTKDM3AKDM6B
SCHEMBL16571847 0.76 NPC1 (0.38) ALDH1A1SMN1; SMN2NPC1RAB9AGRM4
SCHEMBL7513922 0.74 KMO (0.71) ALDH1A1KDM4EMAPTKDM5AKDM3A
SCHEMBL30800092 0.74 KMO (0.71) ALDH1A1KDM4EMAPTKDM5AKDM3A
Hydrochloric Acid SCHEMBL23906970 0.74 NPC1 (0.37) ALDH1A1SMN1; SMN2NPC1RAB9AGRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019055590-A1 BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF AMGEN INC. (US) 2019-03-21 WO disclosed
US-5972975-A Substituted 2-aminopyridines as inhibitors of nitric oxide synthase MERCK & CO., INC. (US) 1999-10-26 US disclosed
WO-1996018616-A1 SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE MERCK & CO., INC. (US) 1996-06-20 WO disclosed
EP-0315997-B1 Cephalosporin compounds and antibacterial agents MEIJI SEIKA KAISHA (JP) 1994-04-20 EP disclosed
EP-0209751-B1 CEPHALOSPORIN DERIVATIVES AND BACTERICIDES CONTAINING THE SAME MEIJI SEIKA KAISHA LTD. (JP) 1992-09-16 EP disclosed
US-5028601-A Substituted with an amino thiazole group and a dihydroxy-pyridone group MEIJI SAIKA KAISHA, LTD. (JP) 1991-07-02 US disclosed
US-4971961-A ANTIBIOTICS AS BACTERICIDES AGAINST PSEUDOMONAS MEIJI SEIKA KAISHA, LTD. (JP) 1990-11-20 US disclosed
EP-0315997-A2 Cephalosporin compounds and antibacterial agents MEIJI SEIKA KAISHA LTD. (JP) 1989-05-17 EP disclosed
EP-0289002-A2 Novel cephalosporin compounds and antibacterial agents MEIJI SEIKA KAISHA LTD. (JP) 1988-11-02 EP disclosed
US-4758557-A Cephalosporin derivatives and bactericides containing the same MEIJI SEIKA KAISHA, LTD. (JP) 1988-07-19 US disclosed
EP-0209751-A2 Cephalosporin derivatives and bactericides containing the same MEIJI SEIKA KAISHA LTD. (JP) 1987-01-28 EP disclosed